U.S. intelligence officials have briefed senators about WuXi AppTec allegedly transferring U.S. intellectual property to China, potentially aiding the Chinese military.

The briefing involved the FBI, Department of State, and Office of the Director of National Intelligence, highlighting risks to U.S. national security.

Proposed legislation aims to curtail U.S. government funding to Chinese companies involved in intellectual property transfer and posing security threats.

The Chinese embassy refutes the allegations, calling them 'unwarranted'.

Both the Senate homeland security committee and the House have taken steps to advance bills restricting business with Chinese biotech firms suspected of military ties.

The Biotechnology Innovation Organization reversed its opposition to the bill due to national security concerns, signaling industry acknowledgment of the risks.

The Biden administration has acted to prevent data transfers to China, citing national security reasons.

Despite WuXi AppTec's denial of the allegations and insistence on compliance with U.S. laws, its stock has suffered, and there is industry support for moving biomanufacturing back to the U.S.